MedTrace Logo

Guilford Genomic Medicine Initiative (GGMI)

NCT01372553 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1184

Last updated 2014-04-16

No results posted yet for this study

Summary

* Genomic medicine, using genetic information to improve health outcomes, is heralded as the answer to rising medical costs by focusing on prevention and tailored care. Despite its potential, little investigation has focused on how genomic medicine can be applied in health care. To be effective, it requires new ways to learn, deliver, and communicate medical information. It will also raise new ethical questions.
* The overall goal of Guilford Genomic Medicine Initiative (GGMI) is to identify the specific challenges in "re-structuring" an existing medical system to integrate genomic medicine, and create solutions that can be used by other medical systems, such as the extensive military medical care system. To accomplish this goal, GGMI includes the development of a large-scale genomic medicine education initiative targeted at the community, providers, and patients, and a clinical systems model to implement strategies to facilitate the integration of genomic medicine into several pilot practices.

Conditions

Sponsors & Collaborators

  • Duke University

    collaborator OTHER

  • University of North Carolina, Greensboro

    collaborator OTHER

  • The Moses H. Cone Memorial Hospital

    lead OTHER

Principal Investigators

  • Geoffrey S Ginsburg, MD, PhD · Duke University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-10-31
Primary Completion
2012-04-30
Completion
2012-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01372553 on ClinicalTrials.gov